Teva Pharmaceutical Industries (TEVA) is set to announce its Q2 2018 earnings results on August 2. Teva is expected to perform better amid the company’s restructuring plans, lower-than-expected Copaxone market share, and sales losses due to competition and reducing debt burden.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,